Effects of excess corticosterone on LKB1 and AMPK signaling in rat skeletal muscle. 2010

G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
Dept. of Physiology and Developmental Biology, Brigham Young Univ., Provo, Utah 84602, USA.

Cushing's syndrome is characterized by marked central obesity and insulin insensitivity, effects opposite those seen with chronic AMP-activated protein kinase (AMPK) activation. This study was designed to determine whether chronic exposure to excess glucocorticoids influences LKB1/AMPK signaling in skeletal muscle. Corticosterone pellets were implanted subcutaneously in rats (hypercorticosteronemia, Hypercort) for 2 wk. Controls were sham operated and fed ad libitum or were sham operated and food restricted (pair-weighted group, Pair) to produce body weights similar to Hypercort rats. At the end of the 2-wk treatment period, rats were anesthetized, and the right gastrocnemius-plantaris (gastroc) and soleus muscles were removed. Left muscles were removed after electrical stimulation for 5 min. No significant differences were noted between treatment groups in ATP, creatine phosphate, or LKB1 activity. The alpha- and beta-subunit isoforms were not significantly influenced in gastroc by corticosterone treatment. Expression of the gamma3-subunit decreased, and gamma1- and gamma2-subunit expression increased. Both alpha2-AMPK and alpha1-AMPK activities were increased in the gastroc in response to electrical stimulation, but the magnitude of the increase was less for alpha2 in the Hypercort rats. Despite elevated plasma insulin and elevated plasma leptin in the Hypercort rats, phosphorylation of TBC1D1 was lower in both resting and stimulated muscle compared with controls. Malonyl-CoA content was elevated in gastroc muscles of resting Hypercort rats. These changes in response to excess glucocorticoids could be responsible, in part, for the decrease in insulin sensitivity and adiposity seen in Cushing's syndrome.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000091162 AMP-Activated Protein Kinase Kinases Protein Serine-threonine kinases that phosphorylate the 63-kDa subunit of AMP-ACTIVATED PROTEIN KINASES. This action results in reactivation of AMP-ACTIVATED PROTEIN KINASE activity and downstream signaling aimed at decreased metabolism. AMP-PK Reactivator,AMP-PK Reactivators,AMPK Kinase,AMP Activated Protein Kinase Kinases,AMP PK Reactivator,AMP PK Reactivators

Related Publications

G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
April 2011, FEBS letters,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
May 2008, Current opinion in clinical nutrition and metabolic care,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
August 2004, American journal of physiology. Endocrinology and metabolism,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
May 2006, American journal of physiology. Endocrinology and metabolism,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
October 2008, Journal of applied physiology (Bethesda, Md. : 1985),
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
December 2000, Bioscience, biotechnology, and biochemistry,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
November 2020, iScience,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
July 1983, Endocrinology,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
May 2005, The EMBO journal,
G Nathan Nakken, and Daniel L Jacobs, and David M Thomson, and Natasha Fillmore, and William W Winder
September 2003, Diabetes,
Copied contents to your clipboard!